AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 527546: 2,5-dimethyl-1-pentyl-1H-pyrrole

Chemical compound data from PubChem database. IUPAC Name: 2,5-dimethyl-1-pentylpyrrole. Molecular Formula: C11H19N. Molecular Weight: 165.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Inpatient Discharges (SPARCS De-Identified): In-Hospital/30-Day Acute Stroke Mortality Rates by Hospital: Beginning 2013

The dataset contains hospital stroke designation and Coverdell registry participation status, acute stroke discharges counts (numerators, denominators), observed, expected and risk-adjusted acute stroke in-hospital/30-day post admission mortality rates with corresponding 95% confidence intervals. Mortality rates risk adjustment was based on the methodology developed by the New York State Department of Health.

The purpose of this data set is reporting of hospital-specific risk adjusted acute stroke mortality rates (RAMR) to inform hospitals, to aid initiatives to improve hospital quality performance and measurement, and to identify performance outliers for public reporting.
Clinical and immunohistochemical study of eight cases with thymic carcinoma

Background
          Thymic carcinoma is a rare neoplasm with extremely poor prognosis. To evaluate the biological characteristics of thymic carcinoma, we reviewed 8 patients.
        
        
          Methods
          There were 2 men and 6 women: ages ranged from 19 to 67 years old (mean 54.8 years). None of these patients had concomitant myasthenia gravis and pure red cell aplasia. No patient had stage I disease, 1 stage II, 5 stage III, and 2 stage IV. The pathologic subtypes of thymic carcinoma included 5 squamous cell carcinomas, 1 adenosquamous cell carcinomas, 1 clear cell carcinoma, and 1 small cell carcinoma. Immunohistochemical study was performed using antibodies against p53, bcl-2, Ki-67, carcinoembryonic antigen (CEA), epithelial membrane antigen (EMA), nm23-H1, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF-2) and factor VIII.
        
        
          Results
          Curative resection could be done in 4 patients (50%). Our data indicates a trend toward an association between complete resection and patient survival. Expression of p53, bcl-2, CEA, EMA, nm23-H1, VEGF and FGF-2 was detected in 5/8, 3/8, 4/8, 5/8, 6/8, 5/8 and 3/8, respectively. Mean Ki-67 labeling index and microvessel density was 7.01 and 34.36 (per 200× field), respectively. When compared with our previous studies, immunohistochemical staining of these proteins in thymomas, the expression rates of these proteins in thymic carcinomas were higher than those in thymomas.
        
        
          Conclusions
          In this small series, it is suggested that a complete resection suggests a favorable result. Immunohistochemical results reveal that the expression of these proteins might indicate the aggressiveness of thymic carcinoma.
Empirical characterization of the expression ratio noise structure in high-density oligonucleotide arrays

Background
          High-density oligonucleotide arrays (HDONAs) are a powerful tool for assessing differential mRNA expression levels. To establish the statistical significance of an observed change in expression, one must take into account the noise introduced by the enzymatic and hybridization steps, called type I noise. We undertake an empirical characterization of the experimental repeatability of results by carrying out statistical analysis of a large number of duplicate HDONA experiments.
        
        
          Results
          We assign scoring functions for expression ratios and associated quality measures. Both the perfect-match (PM) probes and the differentials between PM and single-mismatch (MM) probes are considered as raw intensities. We then calculate the log-ratio of the noise structure using robust estimates of their intensity-dependent variance. The noise structure in the log-ratios follows a local log-normal distribution in both the PM and PM-MM cases. Significance relative to the type I noise can therefore be quantified reliably using the local standard deviation (SD). We discuss the intensity dependence of the SD and show that ratio scores greater than 1.25 are significant in the mid- to high-intensity range.
        
        
          Conclusions
          The noise inherent in HDONAs is characteristically dependent on intensity and can be well described in terms of local normalization of log-ratio distributions. Therefore, robust estimates of the local SD of these distributions provide a simple and powerful way to assess significance (relative to type I noise) in differential gene expression, and will be helpful in practice for improving the reliability of predictions from hybridization experiments.
4.21a Type of care offered in facilities with Opioid Treatment Programs (OTPs), by facility operation and primary focus of facility: 2011. Number

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing the type of care offered in facilities with Opioid Treatment Programs (OTPs), by facility operation and primary focus of facility in 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Patent AT-E401709-T1: [Translated] CYCLE EFFICIENT TDM TIME SLOT REASSIGNMENT FOR NETWORK PROCESSING ENGINES

A method and apparatus for remapping channel data are presented. Multiple successive frames carrying data in timeslots are received. The timeslots are assigned to channels so that data for the channels includes interleaved data. The data from the multiple successive frames for each of a predetermined number of the timeslots are aggregated. The aggregated data is mapped, by timeslot, to produce a timeslot-based map. The aggregated data of the timeslot-based map is remapped to produce a channel-based map in which the data for the channels are grouped together by channel in the order that the data were received.
Safety and Healthcare-Associated Infection Measures - PPS-Exempt Cancer Hospital

Prospective Payment System (PPS)-Exempt Cancer Hospital Quality Reporting (PCHQR) Program Healthcare Associated Infections. These measures are developed by Centers for Disease Control and Prevention (CDC) and collected through the National Healthcare Safety Network (NHSN). They provide information on infections that occur while the patient is in the hospital. These infections can be spread from patient to patient after contact with an infected person or surface. Many healthcare associated infections can be prevented when the hospitals use CDC-recommended infection control steps.
Estradiol gel 0.1%

Estradiol Gel 0.1% is a prescription topical medication containing estradiol, a form of estrogen. It's applied to the skin to help relieve symptoms of menopause, such as hot flashes and vaginal dryness, by replacing declining estrogen levels. Available in packets of 0.25g, 0.5g, or 1g, it's manufactured by Xiromed, LLC. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E401394-T1: [Translated] IMPROVED DNASE LIQUID SOLUTIONS

The present invention relates to the use of calcium ion and/or sugars to minimize thermal aggregation of DNase and to the use of calcium ion to stabilize liquid solutions of DNase, the solutions having a pH of less than neutral. DNase is the active pharmaceutical principle and the solutions may contain other pharmaceutically acceptable excipients making them suitable for pharmaceutical administration. In the first instance, calcium ion/sugar minimizes the effects of thermal aggregation in the solution. In the second aspect, calcium ion stabilizes the lower pH solutions from protein precipitation.
Compound 526238: 1,2,4,6,7-Pentabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,2,4,6,7-pentabromodibenzofuran. Molecular Formula: C12H3Br5O. Molecular Weight: 562.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527829: L-Histidine, 1-methyl-N-(trifluoroacetyl)-, butyl ester

Chemical compound data from PubChem database. IUPAC Name: butyl 3-(1-methylimidazol-4-yl)-2-[(2,2,2-trifluoroacetyl)amino]propanoate. Molecular Formula: C13H18F3N3O3. Molecular Weight: 321.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528390: 2,4-Dichloro-6-hydroxybenzaldehyde

Chemical compound data from PubChem database. IUPAC Name: 2,4-dichloro-6-hydroxybenzaldehyde. Molecular Formula: C7H4Cl2O2. Molecular Weight: 191.01. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40127-T1: [Translated] 1,5-BENZOTHIAZEPINE DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE AND MEDICATIONS.

Novel 1,5-benzothiazepine derivatives of the formula:wherein R' and R<sup>4</sup> are:a) R<sup>1</sup> is lower alkyl or lower alkoxy, and R<sup>4</sup> is lower alkyl, lower alkoxy, fluorine, benzyloxy, hydroxy or lower alkylthio, orb) R' is lower alkyl, and R<sup>4</sup> is hydrogen, orc) R' is hydroxy, and R<sup>4</sup> is lower alkyl, fluorine, hydroxy or lower alkylthio;R<sup>2</sup> is hydrogen, lower alkanoyl or benzoyl; and R<sup>3</sup> is lower alkyl; and a pharmaceutically acceptable acid addition salt thereof are disclosed. In form of pharmaceutical compositions the said derivative (I) and its salt have a potent platelet aggregation-inhibiting activity.
Compound 525545: Chrysophanol-9-anthrone, TMS

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-1,8-bis(trimethylsilyloxy)-10H-anthracen-9-one. Molecular Formula: C21H28O3Si2. Molecular Weight: 384.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527355: 16,20-Dimethyl-triacontyl cyanide

Chemical compound data from PubChem database. IUPAC Name: 17,21-dimethylhentriacontanenitrile. Molecular Formula: C33H65N. Molecular Weight: 475.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
A comparison between two brine shrimp assays to detect

Background
          The brine shrimp lethality assay is considered a useful tool for preliminary assessment of toxicity. It has also been suggested for screening pharmacological activities in plant extracts. However, we think that it is necessary to evaluate the suitability of the brine shrimp methods before they are used as a general bio-assay to test natural marine products for pharmacological activity.
        
        
          Material and Methods
          The bioactivity of the isopropanolic (2-PrOH) extracts of 14 species of marine invertebrates and 6 species of macroalgae was evaluated with the shrimp lethality assay (lethality assay), as well as with another assay based on the inhibition of hatching of the cyst (hatchability assay). The extracts were also assayed for cytotoxicity against two human cell lines, lung carcinoma A-549 and colon carcinoma HT-29, in order to assess the sensitivity of the shrimp assays to detect cytotoxic activity.
        
        
          Results
          Two sponges (Hyatella sp, Dysidea sp.), two gorgonians (Pacifigorgia adamsii, Muricea sp.), one tunicate (Polyclinum laxum), and three echinoderms (Holothuria impatiens, Pseudoconus californica and Pharia pyramidata) showed a strong cytostatic (growth inhibition) and cytotoxic effect. The hatchability assay showed a strong activity in 4 of the species active against the two human cell lines tested (Hyatella sp, Dysidea sp., Pacifigorgia adamsii and Muricea sp.), and the lethality assay also showed a high lethality in 4 of them (Pacifigorgia adamsii, Muricea sp., Polyclinum laxum, and Pharia pyramidata). Each bioassay detected activity in 50% of the species that were considered active against the two human cell lines tested. However, the simultaneous use of both bioassays increased the percentage to 75%.
        
        
          Conclusions
          Our results seem consistent with the correlation previously established between cytotoxicity and brine shrimp lethality in plant extracts. We suggest using both bioassays simultaneously to test natural marine products for pharmacological activity.
Child and Family Services Reviews Update Volume 17, Issue 1, December 2022

This issue of Child and Family Services Reviews Update contains the following sections: Planning for Stakeholder/Partner Engagement Round 4 OSRI, Round 4 FAQs, Round 4 Year 1 Reviews Schedule, and Diverse Agile Staff Sought for CFSRs.

Metadata-only record linking to the original dataset. Open original dataset below.
Genomic regions that underlie soybean seed
isoflavone content

Soy products contain isoflavones (genistein, daidzein, and
glycitein) that display biological effects when ingested by
humans and animals, these effects are species, dose and age
dependent. Therefore, the content and quality of isoflavones in
soybeans is a key to their biological effect. Our objective was
to identify loci that underlie isoflavone content in soybean
seeds. The study involved 100 recombinant inbred lines (RIL) from
the cross of ‘Essex' by ‘Forrest,' two cultivars that contrast
for isoflavone content. Isoflavone content of seeds from each RIL
was determined by high performance liquid chromatography (HPLC).
The distribution of isoflavone content was continuous and
unimodal. The heritability estimates on a line mean basis were
79% for daidzein, 22% for genistein, and 88% for glycitein.
Isoflavone content of soybean seeds was compared against 150
polymorphic DNA markers in a one-way analysis of variance. Four
genomic regions were found to be significantly associated with
the isoflavone content of soybean seeds across both locations and
years. Molecular linkage group B1 contained a major QTL
underlying glycitein content (P = 0.0001, R2 = 50.2%), linkage
group N contained a QTL for glycitein (P = 0.0033, R2 = 11.1%)
and a QTL for daidzein (P = 0.0023, R2 = 10.3%) and linkage
group A1 contained a QTL for daidzein (P = 0.0081, R2 = 9.6%).
Selection for these chromosomal regions in a marker assisted
selection program will allow for the manipulation of amounts and
profiles of isoflavones (genistein, daidzein, and glycitein)
content of soybean seeds. In addition, tightly linked markers can
be used in map based cloning of genes associated with
isoflavone content.
Automated Eligibility Verification System (AEVS): Carrier Codes for Other Health Coverage

This dataset provides basic information about third parties who may be liable for medical expenses that would otherwise be paid by Medi-Cal. This information is based on a point in time and is expected to be updated monthly. The data is retrieved from the Carrier Code Master File (CCMF), which is used to bill liable third parties to ensure Medi-Cal remains the payer of last resort.
Patent AT-E40042-T1: [Translated] DENTAL FILLING COMPOUND CONTAINING AN ADDED POLYVINYLBUTYRAL.

Polyvinyl butyral with a degree of acetalization of at least 75% is added to a dental cement on basis of calcium hydroxide and salicyclic esters of aliphatic alcohols. By this additive improved water resistance and increased compressive strength upon hardening are imparted to the dental cement. The obtained dental cement furthermore has strongly alkaline pH value, so that an effective protection of the pulp can be achieved and formation of a secondary dentin layer is stimulated. In the common formulation of the materials for the dental cement in form of two separate mixing components the polyvinyl butyral can be added either to the mixing component containing the salicylic acid ester or to the mixing component containing the calcium hydroxide, or also to both components.
Quality Assessment of the 2002 to 2013 NSDUH Public Use Files

To meet the increasing needs of researchers at large, NSDUH public use files (PUFs) have been created using a statistical disclosure control technique called MASSC to protect confidentiality of the data. MASSC stands for Micro-Agglomeration, Substitution, Subsampling, and Calibration (Singh, 2002; Singh, Yu, & Dunteman, 2003; Singh, Yu, & Wilson, 2004). MASSC has been successfully used to create NSDUH PUFs since 1999 to control bothdisclosure risk and information loss. Although quality assessment was conducted before releasing each NSDUH PUF to the general public, no formal report had been published until now to document the impact of disclosure treatment on the quality of NSDUH data.
Patent AT-E400361-T1: [Translated] MOISTURE ABSORPTION AND SEMI-TIGHT CONTAINER

To provide a moisture-absorbent unit capable of sufficiently restricting condensation inside a semi-sealed container that can be miniaturized and whose interior is at a comparatively high humidity, when this semi-sealed container undergoes a sharp temperature drop from being placed in a low-temperature environment, and to provide a semi-sealed container having the moisture-absorbent unit. <??>A moisture-absorbent unit used inside a semi-sealed container, this moisture-absorbent unit characterized in having a porous moisture-absorbent material for which the difference in moisture absorption, obtained by subtracting the moisture absorption at a relative humidity of 85% from the moisture absorption at a relative humidity of 95%, is 15% by mass or more of the moisture-absorbent material before absorption. <IMAGE>
Patent AT-E400713-T1: [Translated] DEVICE FOR PUTTY REMOVAL

The tool has a mastic removing tip (28) with a shaft (36) and a head (38) reciprocated by a pneumatic vibration motor (32) operating at a frequency of 120Hz and enclosed in a casing (30). The head, which has a bevelled end with a preferable angle of 30 deg, is made from a polymer material with an optional filler of carbon or glass fibres. The tool is stowed in a container with spaces for cables and a compressed air connector and regulator.
Iowa (IA)

This report presents Iowa\'s estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Iowa for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 525301: 1-Chloroprop-1-en-2-yloxybenzene

Chemical compound data from PubChem database. IUPAC Name: 1-chloroprop-1-en-2-yloxybenzene. Molecular Formula: C9H9ClO. Molecular Weight: 168.62. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Publications Using SAMHSA DataBehavioral Health Barometer: Florida, 2014

This is a behavioral health report for the state of Florida. It uses the National Survey on Drug Use and Health (NSDUH) and the National Survey of Substance Abuse Treatment Services (NSSATS) to address the topics of youth substance use, youth mental health and treatment, adult mental health and treatment, substance use, and substance use treatment for the years 2009 to 2013.
Compound 527335: 2-(2,5-Dimethylphenyl)adamantane

Chemical compound data from PubChem database. IUPAC Name: 2-(2,5-dimethylphenyl)adamantane. Molecular Formula: C18H24. Molecular Weight: 240.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
CMS Program Statistics - Medicare Part A & Part B - All Types of Service

The CMS Program Statistics - Medicare Part A & Part B - All Types of Service tables provide use and payment data by type of coverage and type of service. 

For additional information on enrollment, providers, and Medicare use and payment, visit the CMS Program Statistics page.

 

Below is the list of tables:


	MDCR SUMMARY AB 1.  Medicare Part A and Part B Summary: Utilization, Program Payments, and Cost Sharing for All Original Medicare Beneficiaries, by Type of Coverage and Type of Service, Yearly Trend
	MDCR SUMMARY AB 2.  Medicare Part A and Part B Summary:  Utilization, Program Payments, and Cost Sharing for Aged Original Medicare Beneficiaries, by Type of Coverage and Type of Service, Yearly Trend
	MDCR SUMMARY AB 3.  Medicare Part A and Part B Summary:  Utilization, Program Payments, and Cost Sharing for Disabled Original Medicare Beneficiaries by Type of Coverage and Type of Service, Yearly Trend
	MDCR SUMMARY AB 4.  Medicare Part A and Part B Summary:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Type of Coverage, Demographic Characteristics, and Medicare-Medicaid Enrollment Status
	MDCR SUMMARY AB 5.  Medicare Part A and Part B Summary:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Type of Coverage and by Area of Residence
	MDCR SUMMARY AB 6.  Medicare Part A and Part B Summary:  Utilization and Program Payments for Original Medicare Beneficiaries, by Type of Entitlement, Amount of Program Payments, Type of Coverage, and Type of Service
Compound 526276: 1,3,6-Tribromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,6-tribromodibenzofuran. Molecular Formula: C12H5Br3O. Molecular Weight: 404.88. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399603-T1: [Translated] DEVICE FOR TREATING BULK GOODS

A bulk material processing apparatus (10) which comprises: a longitudinally extending main frame (11); a supply conveyor (23) mounted on, and extending lengthwise of the main frame (11), and operative to convey a supply of bulk material from a forward lower end of the conveyor to an upper and rearward discharge end (24); a material processing device (13) mounted on the main frame (11) and arranged to receive material from the discharge end (24) of the supply conveyor (23), to process the material, and to discharge processed material; a discharge conveyor (32) mounted on the main frame (11) below the processing device (16) so as to be able to receive processed material discharged by the processing device, and to discharge the material to a discharge point located rearwardly of the apparatus; means (16, 17, 18) mounting the processing device (13) on the main frame (11) for movement between a raised operating position to a lowered transport position; and, means (34) mounting the discharge conveyor (32) on the main frame (11) for movement between a raised operative position and a lowered inoperative position; in which the discharge conveyor (32) has a first part (32a) which is mounted on the main frame, and a second part (32b) which is adjustable between an operative position in which it forms a prolongation of the first part, and a folded transport position in which it extends below the first part.